Teekay Corp Ltd

TK NYSE SEC CIK 911971
Follow Teekay Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2B$3BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$949.5M$98.1M
FY24$1.2B$133.8M
FY23$1.5B$150.6M
FY22$1.2B$78.4M
FY21$682.5M$7.8M
FY20$1.1B−$82.9M
FY19$1.3B−$310.6M
FY18$1.7B−$79.2M
FY17$1.9B−$163.3M
FY16$2.3B−$123.2M
FY15$2.5B$82.2M
FY14$2B−$54.8M
FY13$1.8B−$114.7M
FY12$2B−$160.2M
FY11$2B−$358.6M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%0%50%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2566.6%31.9%10.3%
FY2466.8%29.9%11%
FY2367.6%36.3%10.3%
FY2258.4%20.6%6.6%
FY2153.8%−27.2%1.1%
FY2074.1%6.1%−7.2%
FY1968.4%−8.6%−24.4%
FY1876.3%9.5%−4.6%
FY1791.8%0.4%−8.7%
FY1694.1%16.5%−5.3%
FY1595.3%25.5%3.4%
FY1493.6%21.4%−2.7%
FY1393.9%3.4%−6.3%
FY12-−7.6%−8.1%
FY11-5.5%−18.1%
Free cash flowOperating cash flow minus capital expenditure
−$1.5B−$1B−$500M$0$500M$1BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$111.5M
FY24$396.7M
FY23$629.8M
FY22$199.2M
FY21$56.7M
FY20$968M
FY19$371.7M
FY18−$511.7M
FY17−$509.8M
FY16$28.2M
FY15−$1B
FY14−$548.6M
FY13−$461.2M
FY12−$234.7M
FY11-
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$100M$200M$300MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$85.3M$4.9M
FY24$85M$66.3M
FY23$0$50.7M
FY22$0$15.4M
FY21$0$0
FY20$0$0
FY19$5.5M$25.7M
FY18$22.1M$0
FY17$19M$0
FY16$17.4M-
FY15$125.9M-
FY14$91M-
FY13$90.3M$12M
FY12$83.3M$0
FY11$93.5M$122.2M
Net margin vs the sectorMedian of Industrials companies filing with the SEC
  • Teekay
  • Industrials median
−30%−20%−10%0%10%20%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearTeekayIndustrials median
FY2510.3%2.5%
FY2411%3.3%
FY2310.3%3.7%
FY226.6%3.8%
FY211.1%3.7%
FY20−7.2%0.3%
FY19−24.4%3.8%
FY18−4.6%3.9%
FY17−8.7%4%
FY16−5.3%3.8%
FY153.4%4.4%
FY14−2.7%4.8%
FY13−6.3%4.9%
FY12−8.1%4.6%
FY11−18.1%4.8%